- Home
- EXK vs MDXG Comparison
EXK vs MDXG Comparison
Compare EXK & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EXK
- MDXG
- Stock Information
- Founded
- EXK 1981
- MDXG 2006
- Country
- EXK Canada
- MDXG United States
- Employees
- EXK N/A
- MDXG N/A
- Industry
- EXK Precious Metals
- MDXG Biotechnology: Pharmaceutical Preparations
- Sector
- EXK Basic Materials
- MDXG Health Care
- Exchange
- EXK Nasdaq
- MDXG Nasdaq
- Market Cap
- EXK 1.2B
- MDXG 1.2B
- IPO Year
- EXK N/A
- MDXG N/A
- Fundamental
- Price
- EXK $3.78
- MDXG $6.68
- Analyst Decision
- EXK Strong Buy
- MDXG Strong Buy
- Analyst Count
- EXK 3
- MDXG 3
- Target Price
- EXK $6.83
- MDXG $12.00
- AVG Volume (30 Days)
- EXK 13.2M
- MDXG 587.5K
- Earning Date
- EXK 05-13-2025
- MDXG 04-30-2025
- Dividend Yield
- EXK N/A
- MDXG N/A
- EPS Growth
- EXK N/A
- MDXG N/A
- EPS
- EXK N/A
- MDXG 0.28
- Revenue
- EXK $217,639,000.00
- MDXG $348,879,000.00
- Revenue This Year
- EXK $59.94
- MDXG $10.04
- Revenue Next Year
- EXK $32.12
- MDXG $11.53
- P/E Ratio
- EXK N/A
- MDXG $23.86
- Revenue Growth
- EXK 5.93
- MDXG 8.52
- 52 Week Low
- EXK $2.42
- MDXG $5.47
- 52 Week High
- EXK $5.67
- MDXG $10.14
- Technical
- Relative Strength Index (RSI)
- EXK 45.72
- MDXG 32.24
- Support Level
- EXK $2.95
- MDXG $6.55
- Resistance Level
- EXK $4.26
- MDXG $7.34
- Average True Range (ATR)
- EXK 0.33
- MDXG 0.36
- MACD
- EXK 0.02
- MDXG -0.04
- Stochastic Oscillator
- EXK 60.14
- MDXG 15.75
About EXK Endeavour Silver Corporation (Canada)
Endeavour Silver Corp is a Canadian mineral company engaged in the evaluation, acquisition, exploration, development, and exploitation of precious metal properties in Mexico and Chile. The Company has two operating mining segments which are located in Mexico, Guanacevi and Bolanitos. The company has one development project in Mexico, Terronera, as well as Exploration and Corporate segments. The Exploration segment consists of projects in the exploration and evaluation phases in Mexico, Chile, and the USA.
About MDXG MiMedx Group Inc
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are primarily targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.